Are Pain Polymorphisms Associated with the Risk and Phenotype of Post-COVID Pain in Previously Hospitalized COVID-19 Survivors?

dc.contributor.authorFernández-de-las-Peñas, César
dc.contributor.authorGiordano, Rocco
dc.contributor.authorDíaz-Gil, Gema
dc.contributor.authorGil-Crujera, Antonio
dc.contributor.authorGómez-Sánchez, Stella Maris
dc.contributor.authorAmbite-Quesada, Silvia
dc.contributor.authorArendt-Nielsen, Lars
dc.date.accessioned2024-11-20T14:26:27Z
dc.date.available2024-11-20T14:26:27Z
dc.date.issued2022-07-26
dc.description.abstractObjective: To investigate the association of different, selected pain polymorphisms with the presence of de novo long-COVID pain symptoms and to analyze the association between these polymorphisms with clinical, sensory-related, cognitive and psychological variables in COVID-19 survivors. Methods: Two hundred and ninety-three (n = 293, 49.5% female, mean age: 55.6 12.9 years) previously hospitalized COVID-19 survivors participated. Three genotypes of the following single nucleotide polymorphisms (SNPs) were obtained from non-stimulated saliva: OPRM1 (rs1799971), COMT (rs4680), BDNF (rs6265), and HTR1B (rs6296) by polymerase chain reactions in all participants. Further, clinical (intensity/duration of pain), sensory-related (sensitization-associated symptoms, neuropathic pain features), psychological (anxiety or depressive levels, sleep quality), and cognitive (catastrophizing, kinesiophobia) variables were collected in those COVID-19 survivors suffering from post-COVID pain. Analyses were carried out to associate clinical features with genotype. Results: Participants were assessed 17.8 +/- 5.2 months after hospitalization. One hundred and seventeen (39.9%) experienced post-COVID pain (particularly of musculoskeletal origin). The distributions of the genotype variants of any SNP were not significantly different between COVID-19 survivors with and without long-term post-COVID pain (all, p > 0.178). No differences in sensitization-associated symptoms, neuropathic pain features, catastrophizing, kinesiophobia levels, anxiety and depressive levels or sleep quality according to the genotype variant in any SNPs were found. No effect of gender was identified. Conclusion: The four SNPs generally associated with pain did not appear to predispose to the development of de novo long-COVID pain symptoms in previously hospitalized COVID-19 survivors. The SNPs were not involved in the phenotypic features of post-COVID pain either.es
dc.identifier.citationFernández-de-las-Peñas, C.; Giordano, R.; Díaz-Gil, G.; Gil-Crujera, A.; Gómez-Sánchez, S.M.; Ambite-Quesada, S.; Arendt-Nielsen, L. Are Pain Polymorphisms Associated with the Risk and Phenotype of Post-COVID Pain in Previously Hospitalized COVID-19 Survivors? Genes 2022, 13, 1336. https://doi.org/10.3390/genes13081336
dc.identifier.doi10.3390/genes13081336es
dc.identifier.urihttps://hdl.handle.net/10115/41834
dc.language.isoenges
dc.rightsAttribution 4.0 International
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectsingle nucleotide polymorphismes
dc.subjectCOVID-19es
dc.subjectpaines
dc.subjectpost-COVIDes
dc.subjectriskes
dc.titleAre Pain Polymorphisms Associated with the Risk and Phenotype of Post-COVID Pain in Previously Hospitalized COVID-19 Survivors?es
dc.typeinfo:eu-repo/semantics/articlees

Archivos

Bloque original

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
2022_Are polymorphisms associated.pdf
Tamaño:
296.54 KB
Formato:
Adobe Portable Document Format
Descripción:
Artículo

Bloque de licencias

Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
2.67 KB
Formato:
Item-specific license agreed upon to submission
Descripción: